Table 4 Multivariate analysis for variables as predictors for remission
From: Efficacy of Anti-Thyroid Medications in Patients with Graves’ Disease
Effect | Beta | Standard Error | Odds Ratio | [95% Conf. Interval] | P-value |
|---|---|---|---|---|---|
Free T4 upon diagnosis | 0.0240 | 0.0252 | 1.024 | ( 0.97, 1.08 ) | 0.3406 |
TSH receptor antibodies level up on diagnosis | 0.0550 | 0.0260 | 1.057 | ( 1.00, 1.11 ) | 0.0341 |
Thyroid scan and uptake up on diagnosis | 0.0121 | 0.0137 | 1.012 | ( 0.99, 1.04 ) | 0.3783 |
Gender | -0.6922 | 0.4567 | 0.500 | ( 0.20, 1.23 ) | 0.1296 |
Ophthalmopathy severity(mild versus moderate and sever) | -1.4539 | 0.5337 | 0.234 | ( 0.08, 0.67 ) | 0.0064 |
Age | 0.0212 | 0.0171 | 1.021 | ( 0.99, 1.06 ) | 0.2141 |
Duration of ATDs treatment | 0.00110 | 0.00868 | 1.001 | ( 0.98, 1.02 ) | 0.8994 |